The protective effect observed in our study may be associated with the unique phenotype of CD39+ Tregs, which could modulate extracellular adenosine levels in the tumor microenvironment, thereby maintaining immune homeostasis and potentially preventing tumor progression [52,53]. This evidence concerns the gene ENTPD1 and neoplasm.